Target intelligence / Profile preview

Dystrophia Myotonica-Protein Kinase Transcript CUG Repeat Expansion (CUG Expansion)

Target
CUG Expansion
Molecular classification
RNA, Non-coding RNA, Repeat Expansion
01

Overview

The Dystrophia myotonica-protein kinase transcript CUG repeat expansion is a pathogenic molecular event underlying myotonic dystrophy type 1 (DM1). It involves the abnormal expansion of CTG trinucleotide repeats in the 3′ untranslated region (3′UTR) of the DMPK gene, leading to toxic gain-of-function effects at the RNA level. The expanded CUG repeat RNA forms stable secondary structures, accumulates in nuclear foci, and sequesters splicing factors like MBNL, causing widespread mis-splicing and contributing to disease pathology. While not a traditional receptor or enzyme, it is a therapeutic target due to its central role in DM1 pathogenesis.

Other names
Expanded CUG repeats in DMPK mRNADMPK 3'UTR CUG repeat expansionToxic CUG RNA
02

Mechanism of action

Engineered PPR proteins bind to expanded CUG-repeat RNAs, reducing RNA toxicity and restoring normal splicing activity.

03

Biological functions

RNA sequestrationSplicing regulation interferenceGene expression dysregulationNuclear retention
04

Disease associations

Myotonic Dystrophy Type 1 (DM1)
05

Safety considerations

Off-target effects of PPR proteinsImmune response to viral vectors (AAV)Specificity of PPR binding to CUG repeats
06

Interacting drugs

PPR proteins targeting CUG repeats
07

Biomarkers

CUG repeat lengthMBNL protein levelsMis-splicing events of specific target genes

Beyond the preview

Go deeper on Dystrophia Myotonica-Protein Kinase Transcript CUG Repeat Expansion (CUG Expansion).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophia Myotonica-Protein Kinase Transcript CUG Repeat Expansion (CUG Expansion).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call